Prevalence and manifestations of HER2-low breast cancer in patients with unrespectable and/or metastatic disease progressing on anticancer therapy: a retrospective study in the GCC region
- Journal of Cancer Prevention & Current Research
-
Salha BJ Al Bader,<sup>1 </sup>Abdullah Altwairgi,<sup>2</sup> Abdulwahab Altourah,<sup>3</sup> Aref Chehal,<sup>4</sup> Aydah AlAwadhi,<sup>4</sup> Diaeddine Trad,<sup>5</sup> Fathi Azribi,<sup>6</sup> Mishari Alzahrani,<sup>7</sup> Muhammad Farooq,<sup>8</sup> Sharif Kullab,<sup>9</sup> Syed Hammad Tirmazy,<sup>8</sup> Mai Behairy,<sup>10</sup> Amgad Kamal,<sup>10</sup> Shereef Elsamany<sup>11</sup>
PDF Full Text
Keywords
breast neoplasms, neoplasm metastasis, receptor, erbB-2, trastuzumab deruxtecan
